Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Agenus Inc (NQ: AGEN )

3.200 USD +0.040 (+1.27%)
Official Closing Price Updated: 7:39 PM EST, Mar 5, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Agenus Inc

< Previous 1 2 3 4 5 6 7 8 9
...
30 31 Next >
Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2020 Financial Report
Conference Call on Monday, March 15, 2021 at 8:30 a.m. ET 
From GlobeNewswire News Releases
Implied IDNA Analyst Target Price: $56
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Andy Hurley Named Agenus Chief Commercial Officer
From GlobeNewswire News Releases
Agenus Announces Agenus Insights - Virtual R&D Miniseries
From GlobeNewswire News Releases
Agenus Announces New Responses for AGEN1181
From GlobeNewswire News Releases
The Daily Biotech Pulse: J&J Files For COVID-19 Vaccine Approval, Zimmer Biomet's Spin-Off, IPO Deluge Hits Street
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Penny Stocks NARI TWST
From Benzinga
Jon Najarian Sees Unusual Option Activity In JetBlue Airways, Agenus
On CNBC's "Fast Money Halftime Report," Jon Najarian discussed some unusual option activity plays. He sees unusual ... 
Tags Benzinga JBLU Small Cap
From Benzinga
Notable Thursday Option Activity: AGEN, NVDA, TTD
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Agenus Inc (AGEN), where a total volume of 53,776 contracts has been traded thus... 
Tags Stocks
From Market News Video
Encouraging Interim Data From Early-Stage COVID-19 Study With Cell Therapy Lifts Agenus Shares
Agenus Inc(NASDAQ:AGEN) has announcedpositive preliminary resultsfrom its Phase 1 trial evaluating its iNKT ... 
Tags Market News Top Stories Small Cap
From Benzinga
Thinking about buying stock in Canopy Growth Corp, 3D Systems, Bilibili, Agenus, or Vyne Therapeutics?
InvestorsObserver issues critical PriceWatch Alerts for CGC, DDD, BILI, AGEN, and VYNE. 
From PR Newswire
Agenus Announces Positive Preliminary Results of iNKT Cell Therapy Trial in COVID-19
From GlobeNewswire News Releases
Best Penny Stocks To Buy Before Friday? 4 Under $4 To Watch
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Agenus Enters into Clinical Collaboration with Nelum for Zalifrelimab Combination
From GlobeNewswire News Releases
Agenus to Participate in B. Riley Securities' Oncology Investor Conference
From GlobeNewswire News Releases
Implied LABU Analyst Target Price: $160
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Add Up The Pieces: XBI Could Be Worth $185
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
12 Healthcare Stocks Moving In Thursday's Pre-Market Session
Gainers Iterum Therapeutics (NASDAQ:ITRM) stock moved upwards by 35.38% to $0.88 during Thursday's pre-market ... 
Tags Benzinga NTEC ENLV
From Benzinga
Completion of Balstilimab BLA Filing Extended To 1H2021
Agenus to fulfill FDA feedback for six-month follow-up on late responders 
From GlobeNewswire News Releases
3 Penny Stocks To Buy According To Analysts; 107%-195% Price Targets
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Agenus Launches Phase 2 Trial Expansion in Colon Cancer for AGEN1181 in Combination with Balstilimab
New objective response in colon cancer triggers trial expansion 
From GlobeNewswire News Releases
Agenus to Participate in Evercore ISI 3rd Annual HealthCONx Conference
From GlobeNewswire News Releases
VBI Vaccines Announces Positive Interim Phase 2a Data from VBI-1901 in Recurrent GBM
VBI Vaccines Inc. (Nasdaq: VBIV) ("VBI") a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced Phase 2a (Part B) data... 
From Business Wire News Releases
Agenus to Participate in Fireside Chat at the Jefferies 2020 Virtual London Healthcare Conference
From GlobeNewswire News Releases
Agenus and Dr. Steven O’Day to Participate in Webcast Hosted by William Blair on AGEN1181 and SITC Data
From GlobeNewswire News Releases
Agenus and Dr. Steven O’Day to Participate in Panels at the Virtual SITC 2020 Immuno-Oncology Event Hosted by B. Riley
From GlobeNewswire News Releases
The Daily Biotech Pulse: Five Prime Skyrockets, Multiple Conference Presentations On Tap
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ESPR BNTX KRMD
From Benzinga
XOMA Earns First Milestone Payment from 2018 Royalty Purchase Agreement
From GlobeNewswire News Releases
An Agenus-discovered first-in-class ILT4 antibody, MK-4830, enters Phase 2
From GlobeNewswire News Releases
Agenus Presents Additional Clinical Responses and Novel Biomarker Data at SITC2020
From GlobeNewswire News Releases
The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions
Biotech stocks turned around with the broader market in the week ended Nov. 6, as investors warmed to the idea of a split Congress and a ... 
Tags ADMP HTGM AGRX
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
30 31 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.